GSK_Annual_Report_2021

Statutory Reports GlaxoSmithKline Pharmaceuticals Limited 68  Registrar and Share Transfer Agent KFin Technologies Private Limited (previously known as Karvy Fintech Private Limited) Unit: GlaxoSmithKline Pharmaceuticals Limited Selenium Tower B, Plot No 31 and 32 Gachibowli, Financial District, Nanakramguda, Serilingampally Hyderabad, Telangana – 500032 Tel No.: 040 - 67162222 Fax No.: 040 - 23001153 Contact Person: Mr. Premkumar Nair Email ID: einward.ris@kfintech.com  Share transfer system All the transfers received are processed by the Registrars and Share Transfer Agents and are approved by the Share Transfer Committee, which normally meets two times in a month or more depending on the volume of transfers. Share transfers are registered and returned within maximum of 15 days from the date of lodgment if documents are complete in all respects.  Dematerialisation of shares and liquidity 98.69% of the paid-up capital has been dematerialised as on 31 March 2021. Glaxo Group Limited, GlaxoSmithKline Pte Limited, Eskaylab Limited and Burroughs Wellcome International Limited, who jointly hold 75.00% of the paid-up share capital of the company, hold their shares in the dematerialised form.  Outstanding GDRs/ADRs/ Warrants or any convertible instruments conversion date and likely impact on equity Not issued.  Address for correspondence Shareholders’ correspondence should be addressed to the company’s Registrars and Share Transfer Agents at the address mentioned above. Shareholders may also contact Mr. Ajay Nadkarni, Company Secretary, at the Registered office of the company for any assistance. Tel. nos. 022- 24959595 Extension 433/434/415 Email ID : ajay.a.nadkarni@gsk.com Shareholders holding shares in electronic mode should address all their correspondence to their respective Depository Participant.  Plant A-10, M I D C Area - Ambad, Nashik, Maharashtra 422001 10. OTHER DISCLOSURES  Transactions with related parties are disclosed in Note 51 to the standalone financial statements in the Annual Report.  Company has not obtained any credit rating for the financial year ended 31 March 2021.  Company has not raised any funds through preferential allotment or QIP for the financial year ended 31 March 2021.  Company has paid 113.74 lakhs as total fees for all services provided by Deloitte Haskins & Sells LLP, Statutory Auditors of the company.